Oslo Pensjonsforsikring AS bought a new position in shares of The Allstate Corporation (NYSE:ALL – Free Report) in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund bought 156,841 shares of the insurance provider’s stock, valued at approximately $32,519,000. Allstate makes up about 5.1% of Oslo Pensjonsforsikring AS’s portfolio, making the stock its 4th biggest position.
A number of other hedge funds also recently made changes to their positions in the stock. MV Capital Management Inc. acquired a new position in Allstate during the 4th quarter worth approximately $25,000. Dorato Capital Management acquired a new stake in Allstate in the fourth quarter valued at approximately $27,000. Navalign LLC acquired a new stake in Allstate in the fourth quarter valued at approximately $27,000. Evolution Wealth Management Inc. grew its stake in shares of Allstate by 7,000.0% during the first quarter. Evolution Wealth Management Inc. now owns 142 shares of the insurance provider’s stock worth $29,000 after buying an additional 140 shares during the last quarter. Finally, Marshall & Sterling Wealth Advisors Inc. acquired a new position in shares of Allstate during the first quarter worth $30,000. 76.47% of the stock is currently owned by institutional investors and hedge funds.
Insider Transactions at Allstate
In other news, insider Mark Q. Prindiville sold 1,550 shares of the firm’s stock in a transaction dated Friday, May 22nd. The stock was sold at an average price of $216.27, for a total value of $335,218.50. Following the completion of the sale, the insider directly owned 27,558 shares in the company, valued at $5,959,968.66. This trade represents a 5.32% decrease in their position. The sale was disclosed in a filing with the SEC, which is available at this link. Also, Director Andrea Redmond sold 2,225 shares of the business’s stock in a transaction dated Monday, June 1st. The shares were sold at an average price of $202.91, for a total value of $451,474.75. Following the completion of the sale, the director directly owned 2,225 shares of the company’s stock, valued at $451,474.75. The trade was a 50.00% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders have sold 22,353 shares of company stock valued at $4,851,560 in the last 90 days. 1.55% of the stock is currently owned by corporate insiders.
Allstate Stock Performance
Allstate (NYSE:ALL – Get Free Report) last issued its quarterly earnings results on Wednesday, April 29th. The insurance provider reported $10.65 earnings per share (EPS) for the quarter, beating the consensus estimate of $7.31 by $3.34. The firm had revenue of $16.94 billion for the quarter, compared to analyst estimates of $15.24 billion. Allstate had a return on equity of 42.66% and a net margin of 17.81%.The company’s revenue was up 3.0% compared to the same quarter last year. During the same period in the previous year, the firm earned $3.53 earnings per share. As a group, equities research analysts expect that The Allstate Corporation will post 30.51 earnings per share for the current year.
Allstate Dividend Announcement
The business also recently disclosed a quarterly dividend, which will be paid on Thursday, October 1st. Stockholders of record on Monday, August 31st will be issued a dividend of $1.08 per share. The ex-dividend date is Monday, August 31st. This represents a $4.32 annualized dividend and a dividend yield of 1.7%. Allstate’s dividend payout ratio is currently 9.53%.
Wall Street Analysts Forecast Growth
A number of research analysts have recently commented on the company. Atlantic Securities set a $319.00 price target on Allstate in a research note on Wednesday, July 15th. Cantor Fitzgerald upped their target price on Allstate from $236.00 to $242.00 and gave the stock a “neutral” rating in a report on Thursday, July 9th. Citigroup upped their target price on Allstate from $221.00 to $226.00 and gave the stock a “neutral” rating in a report on Friday, May 1st. Mizuho increased their target price on Allstate from $255.00 to $272.00 and gave the company an “outperform” rating in a research report on Thursday, July 9th. Finally, UBS Group cut Allstate from a “buy” rating to a “neutral” rating and boosted their price target for the stock from $255.00 to $261.00 in a report on Wednesday, July 15th. Three analysts have rated the stock with a Strong Buy rating, six have assigned a Buy rating, twelve have assigned a Hold rating and one has given a Sell rating to the stock. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average target price of $254.80.
Get Our Latest Stock Analysis on ALL
Allstate Profile
Allstate Corporation is a publicly traded insurance company headquartered in Northbrook, Illinois, and is one of the largest personal lines property and casualty insurers in the United States. Founded in 1931 as a subsidiary of Sears, Roebuck and Co, Allstate has grown into a diversified insurer that serves millions of consumers and businesses through a mix of distribution channels and product offerings.
The company underwrites a broad range of insurance products, with primary emphasis on auto and homeowners coverage.
Featured Stories
- Five stocks we like better than Allstate
- Confidence Is Back, But Earnings Show the Consumer Is Being Picky
- AeroVironment’s Stock Is Down, But Drone Demand Is Taking Off
- 3M’s Redemption Arc: Can Q2 Earnings Change the Narrative?
- 3 Photonics Companies Making Quantum Tech Possible
Want to see what other hedge funds are holding ALL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Allstate Corporation (NYSE:ALL – Free Report).
Receive News & Ratings for Allstate Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Allstate and related companies with MarketBeat.com's FREE daily email newsletter.
